Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Mpox (And Meningitis) – Risk, Treatments, Vaccines and HIV Overlap

Mpox (And Meningitis) – Risk, Treatments, Vaccines and HIV Overlap

FromThe Academy Exchange: HIV Today & Tomorrow


Mpox (And Meningitis) – Risk, Treatments, Vaccines and HIV Overlap

FromThe Academy Exchange: HIV Today & Tomorrow

ratings:
Length:
31 minutes
Released:
Oct 18, 2022
Format:
Podcast episode

Description

Dr. Richard Silvera joins Bruce to discuss Monkeypox and Meningococcus and how the lessons learned from HIV outbreak response are applicable to these infectious diseases. They discuss the epidemiology of monkeypox and meningococcus disease and the nuances between sexually transmitted infections and those spread by intimate contact. With the public being more aware of the importance of vaccines, it’s important to understand how healthcare providers can best respond to outbreaks of monkeypox and meningococcus.About Dr. Silvera:Dr. Richard Silvera is an Assistant Professor of Infectious Diseases and the Associate Program Director of the Infectious Diseases fellowship at the Icahn School of Medicine at Mount Sinai. Resources:CDC Risk Reduction RecommendationsAnti-stigma Communication RecommendationsNew Vaccine Eligibility Recommendations******** Questions about this topic? E-mail podcast@aahivm.org to get connected with Bruce or any of our guests. Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians! To learn more about the Academy, visit www.aahivm.org
Released:
Oct 18, 2022
Format:
Podcast episode

Titles in the series (12)

In the Academy Exchange, we discuss the latest advances in HIV prevention, care and treatment as well as examine the societal and systemic issues facing people with and at risk for HIV. Brought to you by the American Academy of HIV Medicine and its Executive Director, Bruce Packett, this series of interviews with clinical, research, epidemiological, public health and advocacy experts will demystify the current HIV landscape and point towards future developments. To learn more about the Academy, visit: https://aahivm.org.